{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T07:03:39Z","timestamp":1784531019499,"version":"3.55.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,19]]},"DOI":"10.7759\/cureus.112983","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T06:22:24Z","timestamp":1784528544000},"source":"Crossref","is-referenced-by-count":0,"title":["Association of Serum Interleukin-17 Levels With Vitiligo: A Pilot Cross-Sectional Comparative Study"],"prefix":"10.7759","author":[{"given":"Towfiq","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munir","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Abul Kalam","family":"Azzad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ATM","family":"Asaduzzaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Abul Kalam","family":"Azad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjun","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Abir","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanzina Begum","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wasi Deen","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marufa","family":"Shahrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.5826\/dpc.1501a4600","article-title":"Treatment advances in vitiligo: an updated review","volume":"15","author":"Ismail IB","year":"2025","unstructured":"Ismail IB, Bhat YJ, Ul Islam MS. Treatment advances in vitiligo: an updated review. Dermatol Pract Concept. 2025, 15:4600. 10.5826\/dpc.1501a4600","journal-title":"Dermatol Pract Concept"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2340\/actadv.v104.41018","article-title":"Exploring the role of adipose tissue dysregulation in vitiligo pathogenesis: a body composition analysis","volume":"104","author":"Shao X","year":"2024","unstructured":"Shao X, Pan X, Chen T, et al.. Exploring the role of adipose tissue dysregulation in vitiligo pathogenesis: a body composition analysis. Acta Derm Venereol. 2024, 104:adv41018. 10.2340\/actadv.v104.41018","journal-title":"Acta Derm Venereol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.70067","article-title":"Pathogenesis of vitiligo: integrating immune and non-immune cell crosstalk","volume":"53","author":"Inoue S","year":"2026","unstructured":"Inoue S. Pathogenesis of vitiligo: integrating immune and non-immune cell crosstalk. J Dermatol. 2026, 53:188-99. 10.1111\/1346-8138.70067","journal-title":"J Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06627-8","article-title":"The immunological pathogenesis of vitiligo and the potential role of mesenchymal stromal\/stem cells in its treatment","volume":"23","author":"Yang RL","year":"2025","unstructured":"Yang RL, Zhao DZ, Yang YB, et al.. The immunological pathogenesis of vitiligo and the potential role of mesenchymal stromal\/stem cells in its treatment. J Transl Med. 2025, 23:707. 10.1186\/s12967-025-06627-8","journal-title":"J Transl Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/life15050684","article-title":"Comprehensive overview of cytokine interplay in vitiligo: a decade of meta-analyses systematically reviewed","volume":"15","author":"Paganelli A","year":"2025","unstructured":"Paganelli A, Cristofoletti C, Moro F, Corrente A, Colonna L, Scala E, Picardo M. Comprehensive overview of cytokine interplay in vitiligo: a decade of meta-analyses systematically reviewed. Life (Basel). 2025, 15:684. 10.3390\/life15050684","journal-title":"Life (Basel)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1375339","article-title":"A Mendelian randomization study on the causal effects of circulating cytokines on the risk of vitiligo","volume":"11","author":"Liu C","year":"2024","unstructured":"Liu C, Liu X, Xin H, Li X. A Mendelian randomization study on the causal effects of circulating cytokines on the risk of vitiligo. Front Med (Lausanne). 2024, 11:1375339. 10.3389\/fmed.2024.1375339","journal-title":"Front Med (Lausanne)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.17959","article-title":"Regulatory T cell dysregulation in vitiligo: a meta-analysis and systematic review of immune mechanisms and therapeutic perspectives","volume":"64","author":"Lerner G","year":"2025","unstructured":"Lerner G, Nikolaou M, Stoffel C, et al.. Regulatory T cell dysregulation in vitiligo: a meta-analysis and systematic review of immune mechanisms and therapeutic perspectives. Int J Dermatol. 2025, 64:2247-56. 10.1111\/ijd.17959","journal-title":"Int J Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-100919-023531","article-title":"Vitiligo: mechanisms of pathogenesis and treatment","volume":"38","author":"Frisoli ML","year":"2020","unstructured":"Frisoli ML, Essien K, Harris JE. Vitiligo: mechanisms of pathogenesis and treatment. Annu Rev Immunol. 2020, 38:621-48. 10.1146\/annurev-immunol-100919-023531","journal-title":"Annu Rev Immunol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adu9360","article-title":"Immune control of functional memory CD8 T cells in normal-appearing vitiligo skin","volume":"11","author":"Migayron L","year":"2025","unstructured":"Migayron L, Merhi R, Avril C, et al.. Immune control of functional memory CD8 T cells in normal-appearing vitiligo skin. Sci Adv. 2025, 11:eadu9360. 10.1126\/sciadv.adu9360","journal-title":"Sci Adv"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.17148","article-title":"Vitiligo and psychological stress: a hypothesis integrating the neuroendocrine and immune systems in melanocyte destruction","volume":"63","author":"Al Abadie MS","year":"2024","unstructured":"Al Abadie MS, Chaiyabutr C, Patel KX, Gawkrodger DJ. Vitiligo and psychological stress: a hypothesis integrating the neuroendocrine and immune systems in melanocyte destruction. Int J Dermatol. 2024, 63:841-3. 10.1111\/ijd.17148","journal-title":"Int J Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2015.04.006","article-title":"Interleukin-17 and innate immunity in infections and chronic inflammation","volume":"60","author":"Isailovic N","year":"2015","unstructured":"Isailovic N, Daigo K, Mantovani A, Selmi C. Interleukin-17 and innate immunity in infections and chronic inflammation. J Autoimmun. 2015, 60:1-11. 10.1016\/j.jaut.2015.04.006","journal-title":"J Autoimmun"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13164919","article-title":"Role of cytokines and chemokines in vitiligo and their therapeutic implications","volume":"13","author":"K\u0105dziela M","year":"2024","unstructured":"K\u0105dziela M, Kutwin M, Karp P, Wo\u017aniacka A. Role of cytokines and chemokines in vitiligo and their therapeutic implications. J Clin Med. 2024, 13:4919. 10.3390\/jcm13164919","journal-title":"J Clin Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.5114\/ada.2022.113612","article-title":"Increased serum levels of interleukin-17 in patients with alopecia areata and non-segmental vitiligo","volume":"39","author":"Tomaszewska KA","year":"2022","unstructured":"Tomaszewska KA, Koz\u0142owska M, Kaszuba A, Lesiak A, Narbutt J, Zalewska-Janowska AM. Increased serum levels of interleukin-17 in patients with alopecia areata and non-segmental vitiligo. Postepy Dermatol Alergol. 2022, 39:195-9. 10.5114\/ada.2022.113612","journal-title":"Postepy Dermatol Alergol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1159\/000506103","article-title":"Vitiligo: a review","volume":"236","author":"Bergqvist C","year":"2020","unstructured":"Bergqvist C, Ezzedine K. Vitiligo: a review. Dermatology. 2020, 236:571-92. 10.1159\/000506103","journal-title":"Dermatology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.914898","article-title":"Perspectives of new advances in the pathogenesis of vitiligo: from oxidative stress to autoimmunity","volume":"25","author":"Wang Y","year":"2019","unstructured":"Wang Y, Li S, Li C. Perspectives of new advances in the pathogenesis of vitiligo: from oxidative stress to autoimmunity. Med Sci Monit. 2019, 25:1017-23. 10.12659\/MSM.914898","journal-title":"Med Sci Monit"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.140.6.677","article-title":"Parametric modeling of narrowband UV-B phototherapy for vitiligo using a novel quantitative tool: the Vitiligo Area Scoring Index","volume":"140","author":"Hamzavi I","year":"2004","unstructured":"Hamzavi I, Jain H, McLean D, Shapiro J, Zeng H, Lui H. Parametric modeling of narrowband UV-B phototherapy for vitiligo using a novel quantitative tool: the Vitiligo Area Scoring Index. Arch Dermatol. 2004, 140:677-83. 10.1001\/archderm.140.6.677","journal-title":"Arch Dermatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.06.880","article-title":"Development and validation of the\u00a0fingertip unit for assessing Facial Vitiligo Area Scoring Index","volume":"86","author":"Bae JM","year":"2022","unstructured":"Bae JM, Zubair R, Ju HJ, et al.. Development and validation of the\u00a0fingertip unit for assessing Facial Vitiligo Area Scoring Index. J Am Acad Dermatol. 2022, 86:387-93. 10.1016\/j.jaad.2021.06.880","journal-title":"J Am Acad Dermatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","author":"World Medical Association","year":"2013","unstructured":"World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013, 310:2191-4. 10.1001\/jama.2013.281053","journal-title":"JAMA"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10071639","article-title":"Current concepts of vitiligo immunopathogenesis","volume":"10","author":"Hla\u010da N","year":"2022","unstructured":"Hla\u010da N, \u017dagar T, Ka\u0161telan M, Brajac I, Prpi\u0107-Massari L. Current concepts of vitiligo immunopathogenesis. Biomedicines. 2022, 10:1639. 10.3390\/biomedicines10071639","journal-title":"Biomedicines"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-020-00447-y","article-title":"Vitiligo, from physiopathology to emerging treatments: a review","volume":"10","author":"Migayron L","year":"2020","unstructured":"Migayron L, Boniface K, Seneschal J. Vitiligo, from physiopathology to emerging treatments: a review. Dermatol Ther (Heidelb). 2020, 10:1185-98. 10.1007\/s13555-020-00447-y","journal-title":"Dermatol Ther (Heidelb)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60763-7","article-title":"Vitiligo","volume":"386","author":"Ezzedine K","year":"2015","unstructured":"Ezzedine K, Eleftheriadou V, Whitton M, van Geel N. Vitiligo. Lancet. 2015, 386:74-84. 10.1016\/S0140-6736(14)60763-7","journal-title":"Lancet"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0749.2006.00355.x","article-title":"The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force","volume":"20","author":"Ta\u00efeb A","year":"2007","unstructured":"Ta\u00efeb A, Picardo M. The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res. 2007, 20:27-35. 10.1111\/j.1600-0749.2006.00355.x","journal-title":"Pigment Cell Res"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.10.048","article-title":"New discoveries in the pathogenesis and classification of vitiligo","volume":"77","author":"Rodrigues M","year":"2017","unstructured":"Rodrigues M, Ezzedine K, Hamzavi I, Pandya AG, Harris JE. New discoveries in the pathogenesis and classification of vitiligo. J Am Acad Dermatol. 2017, 77:1-13. 10.1016\/j.jaad.2016.10.048","journal-title":"J Am Acad Dermatol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13175225","article-title":"Vitiligo: from pathogenesis to treatment","volume":"13","author":"Speeckaert R","year":"2024","unstructured":"Speeckaert R, Caelenberg EV, Belpaire A, Speeckaert MM, Geel NV. Vitiligo: from pathogenesis to treatment. J Clin Med. 2024, 13:5225. 10.3390\/jcm13175225","journal-title":"J Clin Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2016.11.014","article-title":"Vitiligo pathogenesis and emerging treatments","volume":"35","author":"Rashighi M","year":"2017","unstructured":"Rashighi M, Harris JE. Vitiligo pathogenesis and emerging treatments. Dermatol Clin. 2017, 35:257-65. 10.1016\/j.det.2016.11.014","journal-title":"Dermatol Clin"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2013.10.010","article-title":"Innate immune mechanisms in vitiligo: danger from within","volume":"25","author":"Richmond JM","year":"2013","unstructured":"Richmond JM, Frisoli ML, Harris JE. Innate immune mechanisms in vitiligo: danger from within. Curr Opin Immunol. 2013, 25:676-82. 10.1016\/j.coi.2013.10.010","journal-title":"Curr Opin Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/504811-association-of-serum-interleukin-17-levels-with-vitiligo-a-pilot-cross-sectional-comparative-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T06:22:24Z","timestamp":1784528544000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/504811-association-of-serum-interleukin-17-levels-with-vitiligo-a-pilot-cross-sectional-comparative-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,19]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.112983","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,19]]}}}